Re: Masashi Yano, Takashi Imamoto, Hiroyoshi Suzuki et al. The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer …
A Morgentaler - European urology, 2007 - pubmed.ncbi.nlm.nih.gov
Re: Masashi Yano, Takashi Imamoto, Hiroyoshi Suzuki et Al. The clinical potential of
pretreatment serum testosterone level to improve the efficiency of prostate cancer screening …
pretreatment serum testosterone level to improve the efficiency of prostate cancer screening …
1722: Pretreatment Serum Testosterone Level can improve the Efficiency of Prostate Cancer Screening
H Suzuki, M Yano, T Imamoto, T Kato… - The Journal of …, 2007 - auajournals.org
1722: Pretreatment Serum Testosterone Level can improve the Efficiency of Prostate Cancer
Screening Page 1 Vol177, No.4, Supplement, Wednesday, May 23, 2007 50.0 40.0 ..J ~ 30.0 …
Screening Page 1 Vol177, No.4, Supplement, Wednesday, May 23, 2007 50.0 40.0 ..J ~ 30.0 …
The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening
M Yano, T Imamoto, H Suzuki, S Fukasawa, S Kojima… - European urology, 2007 - Elsevier
OBJECTIVES: The aim of the present study was to evaluate the clinical value of the
pretreatment serum testosterone (T) level as a potential predictor of prostate cancer risk in …
pretreatment serum testosterone (T) level as a potential predictor of prostate cancer risk in …
1721: The Observed Correlation between Testosterone Levels and Prostate Specific Antigen Values in a Large Screening Population
ED Crawford, C O'Donnell, AB Barqawi - The Journal of Urology, 2007 - auajournals.org
1721: The Observed Correlation between Testosterone Levels and Prostate Specific Antigen
Values in a Large Screening Population Page 1 Vol177, No.4, Supplement, Wednesday, May …
Values in a Large Screening Population Page 1 Vol177, No.4, Supplement, Wednesday, May …
Low serum testosterone levels are predictive of prostate cancer
Purpose Although hormones play fundamental roles in prostate growth, their clinical
significance is not completely clear. Aims of present study were to assess whether …
significance is not completely clear. Aims of present study were to assess whether …
Prostate Cancer Screening
S Mark - gpcme.co.nz
Prostate Cancer Screening Page 1 Ⅰ Prostate Cancer Screening Stephen Mark Urologist
Christchurch Page 2 Background Ⅰ Consultant Urologist 15 yrs Ⅰ Clinical lecturer Univ of …
Christchurch Page 2 Background Ⅰ Consultant Urologist 15 yrs Ⅰ Clinical lecturer Univ of …
Prostate specific antigen screening.
MC Benson, J McKiernan - The Journal of urology, 2007 - europepmc.org
This is a comment on" Use and awareness of prostate specific antigen tests and
race/ethnicity." J Urol. 2007 Apr; 177 (4): 1475-80; discussion 1480. This is a comment on" …
race/ethnicity." J Urol. 2007 Apr; 177 (4): 1475-80; discussion 1480. This is a comment on" …
[HTML][HTML] Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer
W Song, V Soni, M Khera - Asian Journal of Andrology, 2015 - journals.lww.com
Prostate-specific antigen (PSA) testing has been widely used to screen men for prostate
cancer (PCa) and to monitor PCa progression. However, more studies have shown that …
cancer (PCa) and to monitor PCa progression. However, more studies have shown that …
Serum testosterone: a potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (≥ 3.0 and< …
D Karamanolakis, T Lambou, J Bogdanos… - Anticancer …, 2006 - ar.iiarjournals.org
Whether serum testosterone (T) can become an adjunct test able to validate the PSA-
weighted risk of prostate cancer (PR. CA) in the “grey” diagnostic area (PSA= 3.0 to< 10.0 …
weighted risk of prostate cancer (PR. CA) in the “grey” diagnostic area (PSA= 3.0 to< 10.0 …